Physician profile
Peter D Crane
NPI 1730134362
$2,633.67
in general payments reported to CMS, 2019-2025
19 companies · $894 in 2025
The $894 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.96 · 2023: $238 · 2024: $1,477 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,094 · Travel and Lodging: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,093.87 |
| Travel and Lodging | $515.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,775.70 | 2024-2025 | Intracept |
| Stryker Corporation | $156.21 | 2025 | Mild Device Kit, Multigen 2 |
| Mml US, INC. | $113.40 | 2025 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $87.21 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $66.28 | 2023-2025 | Xtampza |
| Tersera Therapeutics LLC | $57.89 | 2023-2024 | Prialt |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.72 | 2023 | Relistor |
| Scilex Pharmaceuticals INC. | $54.87 | 2024-2025 | |
| Medtronic, INC. | $47.80 | 2023-2025 | Kyphon Express II Kyphopak Tray, Synchromedii |
| Almatica Pharma LLC | $34.72 | 2023 | Gralise |
| Valinor Pharma, LLC | $32.88 | 2024 | Movantik |
| Si-Bone, INC. | $28.16 | 2025 | |
| Protega Pharmaceutials INC | $23.96 | 2022 | |
| Averitas Pharma INC. | $22.82 | 2025 | Qutenza |
| Relievant Medsystems, INC. | $19.38 | 2023 | Intracept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $15.06 | 2024 | Quviviq |
| Amgen INC. | $14.99 | 2023 | Prolia, Evenity |
| Curonix LLC | $13.50 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $13.12 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.